Characteristic | Â | Â |
---|---|---|
Age (n = 23) | Â | 49 (25-71)* |
Race | Â | Â |
 | White | 16 |
 | AA | 6 |
 | Hispanic | 1 |
Tumor Laterality | Â | Â |
 | L | 16 |
 | R | 4 |
 | B/L | 3 |
Tumor Location†|  |  |
 | UOQ | 9 |
 | LOQ | 2 |
 | UIQ | 4 |
 | LIQ | 2 |
 | Chest Wall | 1 |
 | Overlapping | 4 |
 | Unknown | 1 |
Histology | Â | Â |
 | IDC | 21 |
 | ILC | 2 |
Nodal Surgery Radiated Side | Â | Â |
 | SLNB alone | 4 |
 | ALND | 19 |
Type of Reconstruction | Â | Â |
 | Ipsilateral Alone | 10 |
 | Bilateral††| 13 |
Expander Location | Â | Â |
 | Sub Pec Major | 33 |
 | Sub Latissimus Flap§ | 2 |
 | Unknown | 1 |
Clinical Stage | Â | Â |
 | Tis|| | 3 |
 | IA | 5 |
 | IIA | 7 |
 | IIB | 7 |
 | IIIA | 2 |
 | Unknown | 2 |
Pathologic Stage | Â | Â |
 | ypTis | 1 |
 | pTis | 2 |
 | ypT0N0 | 4 |
 | ypIA | 3 |
 | ypIIA | 2 |
pIIA | Â | 3 |
 | ypIIB | 2 |
 | pIIB | 5 |
 | ypIIIA | 3 |
 | pIIIA | 1 |
Systemic Therapy | Â | Â |
 | Neoadjuvant | 13 |
Adjuvant | Â | 10 |